Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra

P. G. Conaghan; M. A. Bowes; Mikkel Østergaard; G. Guillard; D. Chapman; A. Stein; J. Andrews; Z. Xie; A. Koenig; K. Soma; B. Wilkinson

Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra

P. G. Conaghan
, M. A. Bowes
, Mikkel Østergaard
, G. Guillard
, D. Chapman
, A. Stein
, J. Andrews
, Z. Xie
, A. Koenig
, K. Soma
, B. Wilkinson

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme HOC

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	76
Udgave nummer	Suppl 2
Sider (fra-til)	268
Antal sider	1
ISSN	0003-4967
Status	Udgivet - 2017

Citationsformater

Conaghan, P. G., Bowes, M. A., Østergaard, M., Guillard, G., Chapman, D., Stein, A., Andrews, J., Xie, Z., Koenig, A., Soma, K., & Wilkinson, B. (2017). Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra. Annals of the Rheumatic Diseases, 76(Suppl 2), 268.

Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra. / Conaghan, P. G.; Bowes, M. A.; Østergaard, Mikkel et al.
I: Annals of the Rheumatic Diseases, Bind 76, Nr. Suppl 2, 2017, s. 268.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Conaghan, PG, Bowes, MA, Østergaard, M, Guillard, G, Chapman, D, Stein, A, Andrews, J, Xie, Z, Koenig, A, Soma, K & Wilkinson, B 2017, 'Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra', Annals of the Rheumatic Diseases, bind 76, nr. Suppl 2, s. 268.

Conaghan PG, Bowes MA, Østergaard M, Guillard G, Chapman D, Stein A et al. Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra. Annals of the Rheumatic Diseases. 2017;76(Suppl 2):268.

Conaghan, P. G. ; Bowes, M. A. ; Østergaard, Mikkel et al. / Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra. I: Annals of the Rheumatic Diseases. 2017 ; Bind 76, Nr. Suppl 2. s. 268.

@article{7e8b6c1b04c2493eb42770fd137f6414,

title = "Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-na{\"I}ve patients with early ra",

author = "Conaghan, \{P. G.\} and Bowes, \{M. A.\} and Mikkel {\O}stergaard and G. Guillard and D. Chapman and A. Stein and J. Andrews and Z. Xie and A. Koenig and K. Soma and B. Wilkinson",

note = "COPECARE",

year = "2017",

language = "English",

volume = "76",

pages = "268",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

number = "Suppl 2",

}

TY - ABST

T1 - Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra

AU - Conaghan, P. G.

AU - Bowes, M. A.

AU - Østergaard, Mikkel

AU - Guillard, G.

AU - Chapman, D.

AU - Stein, A.

AU - Andrews, J.

AU - Xie, Z.

AU - Koenig, A.

AU - Soma, K.

AU - Wilkinson, B.

N1 - COPECARE

PY - 2017

Y1 - 2017

M3 - Conference abstract in journal

SN - 0003-4967

VL - 76

SP - 268

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

ER -